Scientists test intravenous psychedelic in healthy volunteers to map its effects
NCT ID NCT07444788
First seen Mar 06, 2026 · Last updated Apr 30, 2026 · Updated 7 times
Summary
This study gives healthy adults a single intravenous dose of 5-MeO-DMT (a fast-acting psychedelic) or a placebo to measure its short-term effects on mood, heart rate, and blood levels. Participants are randomly assigned and don't know which they receive. The goal is to understand safety and how the drug works in the body, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for 5-METHOXY-DIMETHYLTRYPTAMINE (5-MEO-DMT) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Hospital Basel
RECRUITINGBasel, Canton of Basel-City, 4056, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.